Long-term outcomes of graves disease in children treated with anti-thyroid drugs

Graves disease (GD) is the most common cause of thyrotoxicosis in children and adolescents, accounting for 15% of all thyroid diseases during childhood. Anti-thyroid drugs (ATD) are recommended as the first-line treatment in children and adolescents. However, the remission rate is lower in children than in adults, and the optimal treatment duration and favorable factors associated with remission remain unknown. We aimed to investigate long-term outcomes of pediatric GD patients receiving ATD.

Source: Pediatrics and Neonatology - January 20, 2020 Category: Perinatology & Neonatology Authors: Ya-Ting Chiang, Wei-Hsin Ting, Chi-Yu Huang, Shih-Kang Huang, Chon-In Chan, Bi-Wen Cheng, Chao-Hsu Lin, Yi-Lei Wu, Chen-Mei Hung, Hsin-Jung Li, Chia-Jung Chan, Yann-Jinn Lee Tags: Original Article Source Type: research